PROXY STATEMENT

Company

ADIAL PHARMACEUTICALS, INC.

Filed

September 27, 2024

Period of Report

November 12, 2024

Accession Number

0001213900-24-082805

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →